Early ALS drug trial halted: safety first in fight against nerve disease
Disease control
Terminated
This early-stage study aimed to test the safety and side effects of an experimental drug called VRG50635 in people with ALS (Lou Gehrig's disease). It involved 54 adults with ALS to see how their bodies handled increasing doses of the drug over time and to look for early signs it…
Phase: PHASE1 • Sponsor: Verge Genomics • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC